Form 4: Absci Director Daniel Rabinovitsj Receives Significant Equity Compensation

Absci Corporation's Director, Daniel A. Rabinovitsj, was granted 14,500 Restricted Stock Units and 57,400 stock options on June 11, 2025, as part of his compensation package.

Summary

• Daniel A. Rabinovitsj, a Director of Absci Corp (ABSI), was granted equity awards on June 11, 2025.
• The awards include 14,500 Restricted Stock Units (RSUs) and 57,400 stock options.
• The RSUs were granted at a price of $0, representing the contingent right to receive one share of Common Stock per unit.
• The stock options have an exercise price of $3.01 per share and an expiration date of June 10, 2035.
• Both the RSUs and stock options will vest in full on the earlier of the first anniversary of the grant date or the date of Absci's next annual meeting of stockholders, subject to continuous service.
• Following these transactions, Mr. Rabinovitsj beneficially owns 23,320 shares of Common Stock directly and 57,400 stock options directly.

Sentiment

Score: 7

Explanation: The document reports a standard equity grant to a director, which is generally positive as it aligns management's interests with shareholders and serves as an incentive for continued service. There are no negative disclosures.

Positives

• Grant of 14,500 Restricted Stock Units (RSUs) to Director Daniel A. Rabinovitsj, aligning his interests with shareholders.
• Grant of 57,400 stock options with an exercise price of $3.01 to Director Daniel A. Rabinovitsj, providing long-term incentive.
• The equity awards are subject to vesting conditions, promoting continuous service and commitment from the director.

Risks

• The value of the granted equity awards is subject to the future performance of Absci Corp's stock price.
• Vesting of the awards is contingent on the reporting person's continuous service to the Issuer, meaning forfeiture could occur if service is terminated before vesting.

Future Outlook

The granted RSUs and stock options are subject to future vesting, which will occur on the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders, provided the reporting person maintains continuous service.

Industry Context

This filing is a routine disclosure of executive compensation in the form of equity grants, common across publicly traded companies, particularly in the biotechnology or technology sectors where equity-based incentives are a standard component of compensation packages to attract and retain talent.

Comparison to Industry Standards

• Equity grants to directors, including RSUs and stock options, are a standard practice in the U.S. public company landscape, particularly for growth-oriented companies like Absci Corp.
• The vesting schedule (one year or next annual meeting) is a common approach to ensure director retention and alignment with long-term shareholder value.
• The exercise price of $3.01 for options is typical for new grants, often set at the market price on the grant date, though the document doesn't explicitly state the market price on 06/11/2025.

Corporate Governance

Related Party Transactions

• The grant of equity awards (14,500 RSUs and 57,400 stock options) to Daniel A. Rabinovitsj, a Director of Absci Corp, constitutes a related party transaction, which is a standard form of compensation and is disclosed as required by SEC regulations.

Stakeholder Impact

• Shareholders: The grants align the director's interests with shareholders, potentially leading to better long-term performance. However, the issuance of new shares upon RSU settlement and option exercise could lead to minor dilution.
• Employees: While not directly impacting all employees, this reflects the company's compensation strategy, which may influence overall employee morale and retention.

Next Steps

• Vesting of 14,500 Restricted Stock Units on the earlier of June 11, 2026, or the date of Absci's next annual meeting of stockholders.
• Vesting of 57,400 stock options on the earlier of June 11, 2026, or the date of Absci's next annual meeting of stockholders.

Key Dates

Keywords

Absci Corp, ABSI, Form 4, SEC filing, insider transaction, equity grant, Restricted Stock Units, RSUs, stock options, director compensation, beneficial ownership, Daniel A. Rabinovitsj